JPRN-jRCT2080221855未知3 期
Phase III Clinical Trial, long term treatment with TO-204 - Subcutaneous immunotherapy in patients with HDM-sensitized allergic rhinitis and asthma
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 5age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •1) Positive test in RAST(specific anti-HDM IgE >= Class 2)
- •2) Positive skin prick/scratch test against HDM allergen
排除标准
- •1) Patients with clinical symptoms of perennial rhinitis or asthma caused by allergen other than HDM
- •2) Patients with severe asthma
- •3) Patients with severe systemic diseases (i.e., auto-immune disease, immunocomplex disease, immunodeficient disease)
研究者
相似试验
进行中（未招募）
不适用
A phase IIIB trial investigating 3-year treatment efficacy, tolerability and safety of Grazax in children aged 5-18 years with grass pollen induced rhinoconjunctivitis with/without controlled controlled asthma ( three consecutive pollen seasons treatment) - GT-23children from 5 to 18 years with grass pollen induced rhinoconjunctivitis with/without controlled asthmaMedDRA version: 9.1Level: LLTClassification code 10054928EUCTR2009-014923-22-ITALK-ABELLO`
已完成
3 期
Phase III Comparative Clinical Trial of Treatment Schedules for Oral UFT/LV Therapy as Postoperative Adjuvant Chemotherapy for Stage IIB/III Colorectal Cancercolorectal cancerJPRN-C000000245Japanese Foundation for Multidisciplinary Treatment of Cancer840
进行中（未招募）
1 期
Phase III Randomized Controlled Trial of Pembrolizumab with or without Chemo vs Chemo in Advanced Urothelial CarcinomaAdvanced or Metastatic Urothelial CarcinomaMedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864EUCTR2015-005731-41-IEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.990
已完成
3 期
A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinomabladder cancerNL-OMON45288Merck Sharp & Dohme (MSD)20
进行中（未招募）
1 期
Phase III Randomized Controlled Trial of Pembrolizumab with or without Chemo vs Chemo in Advanced Urothelial CarcinomaAdvanced or Metastatic Urothelial CarcinomaMedDRA version: 19.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864EUCTR2015-005731-41-ESMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.990